Today: 8 June 2026
Rivian stock drops 5% after CEO share-sale filing as year-end trading thins
31 December 2025
1 min read

Rivian stock drops 5% after CEO share-sale filing as year-end trading thins

NEW YORK, December 30, 2025, 19:28 ET — After-hours

  • Rivian shares closed down about 5.2% at $19.60 and were little changed after the bell.
  • An SEC filing showed CEO R.J. Scaringe sold 17,450 shares on Dec. 23 under a pre-arranged Rule 10b5-1 plan.
  • Investors also parsed Federal Reserve minutes that highlighted sharp divisions over the December rate cut.

Rivian Automotive, Inc. shares fell on Tuesday after a regulatory filing disclosed Chief Executive R.J. Scaringe sold stock under a pre-arranged trading plan. The shares closed down about 5.2% at $19.60 and were little changed in after-hours trading.

The timing matters. With U.S. markets in holiday-thin mode and just one session left in 2025, modest headlines can move high-beta stocks more sharply than usual.

Rivian also traded against a macro backdrop that has kept pressure on rate-sensitive growth names. Federal Reserve minutes released Tuesday underscored divisions around the December decision to cut rates, complicating expectations for how quickly borrowing costs might fall in 2026.

In a Form 4 filed with the U.S. Securities and Exchange Commission, Scaringe reported selling 17,450 shares on Dec. 23 at a weighted-average price of $21.4253. The filing said the shares were sold at prices ranging from $21.21 to $21.69.

Scaringe reported owning 1,150,109 Rivian shares directly after the transaction, plus additional holdings through a trust and an LLC, the filing showed.

The filing said the sale was executed under a Rule 10b5-1 plan — a preset arrangement that lets insiders buy or sell shares on a schedule, designed to reduce the appearance of trading on nonpublic information.

Rivian opened at $20.68 and fell as low as $19.28 during the regular session, with about 38 million shares changing hands, according to price data. The stock finished Monday at $20.67.

Electric-vehicle peers were also lower, though less sharply. Tesla was down about 1.2%, while Lucid slid roughly 1.8%; Ford dipped about 0.3%.

Wall Street’s main indexes ended slightly lower in choppy trade, Reuters reported. “It’s just a healthy rebalancing of allocations more so than an emotionally driven sell-off,” said Mark Hackett, chief market strategist at Nationwide. Reuters

Fed minutes from the Dec. 9–10 meeting showed officials were split over the quarter-point cut that brought the benchmark rate to a 3.5%–3.75% range, Reuters reported. New projections signaled only one cut expected in 2026, and the Fed next meets Jan. 27–28.

For Rivian, the next demand read is its quarterly production and deliveries update; last year the company released its fourth-quarter production and delivery figures in early January. Investors also watch the sector for signals on pricing and incentives as tighter financing conditions and rate expectations ripple through EV demand.

Attention then shifts to earnings. Earnings calendars currently estimate Rivian’s next report around Feb. 19, though the company has not confirmed a date; traders typically focus on gross margin progress, cash burn and any update on spending needed to scale future vehicle programs.

Stock Market Today

  • Constellation Energy's Geothermal Expansion Tests Stock Valuation Amid Pullback
    June 8, 2026, 4:13 PM EDT. Constellation Energy (NasdaqGS:CEG) has completed a 25 MW geothermal expansion at The Geysers, supporting California's renewable goals and building on earlier projects. The unit Calpine, acquired for US$16.4 billion, drives this green energy push. Despite this, Constellation's stock price has dropped 30.4% year-to-date and 14.5% over 12 months, reflecting recent market volatility after a 177.4% rise in three years. Shares traded at US$254.83, about 31% below analysts' US$367.12 target, and 47.6% below estimated fair value per Simply Wall St. Investors should monitor how this capacity and renewables affect earnings, leverage, and the company's longer-term cash flow amid high debt and one-off expenses.

Latest articles

Nasdaq rises as AI names find support after market selloff

Nasdaq rises as AI names find support after market selloff

8 June 2026
Nasdaq surged 1.27% as investors snapped up AI and chip stocks after Friday’s rout, with the Philadelphia Semiconductor Index jumping 6.2%; Citigroup hiked its S&P 500 year-end target to 8,100 on AI demand, but Goldman Sachs warned strong jobs data makes a Fed rate hike more plausible, posing risks to growth stocks if inflation surprises.
Tesla Stock Bounces Over $400 After China Sales Beat—But There’s a Caveat

Tesla Stock Bounces Over $400 After China Sales Beat—But There’s a Caveat

8 June 2026
Tesla shares soared over 5% to $411.66 after a China sales report showed May retail sales up 22.5%, ending a two-month decline, and J.P. Morgan upgraded the stock, citing rising value from autonomy and software; the rally outpaced the Nasdaq as investors bet on Tesla’s China resilience and technology story despite a lofty price-to-earnings ratio of about 378.
Ondas Stock Comes Back Into the Spotlight After 13% Drop; Drone Trade Faces Fresh Challenge

Ondas Stock Comes Back Into the Spotlight After 13% Drop; Drone Trade Faces Fresh Challenge

8 June 2026
Ondas shares slipped 0.5% to $10.38 as investors weighed a new $4.8M U.S. Navy-linked balloon contract and $110M in Q2 orders against high short interest (31.33% of float), rising operating losses, and fresh stock-supply concerns after a June 3 filing revealed more Omnisys-related shares could hit the market, raising dilution risks despite surging revenue and backlog.
Archer Aviation Shares Bounce Back, FAA Timeline and Cash Burn in Focus

Archer Aviation Shares Bounce Back, FAA Timeline and Cash Burn in Focus

8 June 2026
Archer Aviation shares jumped 4.2% to $5.77 after last week’s 13.2% drop, as investors rotated back into growth and air-taxi stocks; the move follows Archer’s milestone as the first eVTOL developer to close Phase 3 of FAA certification, but heavy losses and high cash burn keep the stock highly sensitive to regulatory and financial risks.
SELLAS Life Sciences (SLS) stock jumps on Phase 3 AML trial timing update — what investors watch next
Previous Story

SELLAS Life Sciences (SLS) stock jumps on Phase 3 AML trial timing update — what investors watch next

Newmont stock rebounds as gold steadies after CME margin jolt; Raymond James lifts target
Next Story

Newmont stock rebounds as gold steadies after CME margin jolt; Raymond James lifts target

Go toTop